Marijuana Businesses Can’t Force Court To Do ‘Imaginary’ Rescheduling Review To Exempt Them From 280E Tax, IRS Says

IRS 280E cannabis tax: in the fluorescent hum of federal bureaucracy, the house still gets paid. The Internal Revenue Service just told a U.S. Tax Court—again—that state-legal marijuana businesses don’t get to duck Section 280E’s no-deductions rule until marijuana is formally rescheduled. Not with clever semantics. Not with wishful thinking. And certainly not by asking a tax judge to play pharmacist. For operators betting on cannabis taxation relief via rescheduling, the message is blunt: until the Drug Enforcement Administration signs the paper and posts the final rule, you’re living under the old religion—no ordinary federal tax deductions for selling a Schedule I substance.

Ultra Health’s bet on statutory “meaning,” and the IRS’s cold shower

Ultra Health, a New Mexico operator, tried a novel route. They argued 280E doesn’t just care whether marijuana is listed on Schedule I; it cares whether marijuana fits the statutory “meaning” of Schedule I—no accepted medical use, high abuse potential. And if the science and agencies say that’s no longer true, then the tax code shouldn’t treat it like it is. It’s tidy. It’s also exactly what the IRS says the court can’t do. In a recent filing, the agency reminded the bench that Congress and more than 40 federal opinions have already held 280E is constitutional and applies to marijuana sellers. Rescheduling authority, the IRS stressed, belongs to DEA and HHS, full stop. Until DEA publishes a final rule, marijuana remains Schedule I. Period. If you want the receipts, the agency’s position is now inked into the case record, complete with the “don’t hide an elephant in a mousehole” warning about reading too much into “within the meaning” language. And no, the Tax Court can’t run its own parallel review; that’s an administrative lane, not a judicial shortcut. If you’re also trying to navigate the tightening vise of digital rules, the political weather isn’t exactly clearing either—see how Congress is moving on youth protections that could box in brands’ outreach in Congressional Lawmakers Approve Youth Safety Bill That Could Complicate Marijuana Businesses’ Online Outreach.

Rescheduling isn’t retroactive, and “sister statutes” march in step

Here’s the razor’s edge. HHS and FDA have advised marijuana belongs on Schedule III, and a December executive order directed DOJ to keep the rescheduling train moving. But the IRS told the court that even if rescheduling lands tomorrow, there’s no authority to make it retroactive to the tax years Ultra Health is fighting over—July 2017 through June 2020. Courts apply the law in effect when they decide, and for those years, cannabis was, and today still is, Schedule I. The agency also called the Controlled Substances Act and Section 280E “sister statutes,” built to harmonize: if a drug sits on Schedule I or II under the CSA, it sits “within the meaning” of those schedules for 280E. That’s the choreography. No leaps, no improvisation. And that rider cutting off DOJ funds to mess with state medical markets? It changes enforcement budgets, not the CSA’s black-letter prohibition on sales. Out in the real world, this all lands like a well whiskey at closing time—bracing. It’s also a reminder that operational shortcuts can backfire, just like brittle tech fixes at the register. For a taste of how consumer access tools can create new headaches for seniors and staff, see Marijuana Ordering Kiosks For Seniors Present Both Opportunities And Risks (Op-Ed).

The “imaginary process,” by any other name, is still a no

Ultra Health wanted the court to interrogate the CSA’s three-part criteria and decide marijuana never really belonged on Schedule I—essentially, to read “within the meaning” as license to reassess science and policy. The IRS called that an “imaginary process.” Not because the science is fantasy, but because administrative law isn’t a choose-your-own-adventure. DEA has the pen; HHS carries the clipboard; Tax Court calls balls and strikes on taxes, not pharmacology. There’s also a practical undertow: the industry is already on the agency’s radar for creative filings that claim deductions “without a reasonable basis,” a public warning that arrived like a flashing neon sign. Push too hard, too fast, and you risk turning a tax position into an audit magnet. Meanwhile, the cultural tide keeps lapping at the seawall—data on cannabis and women’s sexual health is surfacing in mainstream analysis, a reminder that medical value doesn’t wait for Washington’s paperwork. If you’re tracking the human side of this science, detour into Marijuana May Be A ‘Gateway To Women’s Orgasm’ In Sexual Health Treatment, Scientific Analysis Finds.

Cannabis taxation today, policy reform tomorrow—bring a map

So where does that leave operators? In the uncomfortable present. You price with 280E baked in. You document cost of goods sold with monk-like discipline. You plan capital and payroll as if deductions don’t exist, because for now, they don’t. Keep a clean file of your state compliance, but don’t confuse state permission with federal absolution. And, crucially, be ready for the snap when rescheduling finally posts. If cannabis moves to Schedule III, 280E’s chokehold eases going forward, not back. That means recalibrated margins, rewired cash flow, and tax strategies that finally look like the rest of Main Street’s. Policy windows open and close fast—just ask the psychedelic reform crowd watching legislatures sketch task forces and access pathways with the tentative hand of a first tattoo. For a sense of how adjacent drug policy is moving, read Hawaii Senate Passes Bill To Create Psychedelics Task Force And Study Pathways To Access Psilocybin And MDMA.

Until rescheduling is real, this is the gritty truth of the Michigan grower, the New Mexico dispensary, the California manufacturer: cannabis industry impact starts with tax math, not vibes. The IRS is not your therapist; it won’t validate your journey. It counts, it disallows, it collects. If the Department of Justice delivers the rule in the “most expeditious manner,” great—pop the cork, then call your accountant. If not, keep your head down and your ledgers clean. The underbelly of marijuana policy reform is paved with filings and footnotes, not slogans. And when you need a moment of clarity between the spreadsheets and the statutes, wander our way and explore what’s fresh—start here: our shop.